SIVAStress: Influence of Screen Sizes on Responses to Visual Analog Scales of Stress

Sponsor
University Hospital, Clermont-Ferrand (Other)
Overall Status
Recruiting
CT.gov ID
NCT04040608
Collaborator
Institut de Médecine du Travail (Other), UMR CNRS 6024, LaPSCo (Other)
200
1
36
5.6

Study Details

Study Description

Brief Summary

Visual analog scales (VAS) are one of the most common tools used in questionnaires. VAS are validated for pain and stress for example on a horizontal, non-calibrated line of 100 mm, ranging from very low (0) to very high (100). Nowadays, most VAS are used on questionnaires on internet. However, the influence of screen sizes on responses to visual analog scales were never studied.

Condition or Disease Intervention/Treatment Phase
  • Other: Influence of screen sizes on responses to visual analog scales of stress

Detailed Description

Visual analog scales (VAS) are one of the most common tools used in questionnaires. VAS are validated for pain and stress for example on a horizontal, non-calibrated line of 100 mm, ranging from very low (0) to very high (100). Nowadays, most VAS are used on questionnaires on internet. However, the influence of screen sizes on responses to visual analog scales were never studied.

Primary objective is to study the influence of screen sizes on response responses to visual analog scales.

Secondary objectives are to assess:
  • the variability of responses depending on screen sizes within a week

  • the influence of perception of work and addiction to work on the variability depending on screen sizes

  • relationships with biomarkers of stress : salivary DHEAS, heart rate variability and skin conductance

An open questionnaire will be created by the Clinical Research Direction. The questionnaire will be opened by the examinator who will fulfill the anonymized identification of participants and the type of screens. In a dedicated room at the LaPSCo, the participants will answer the same VAS on four different sizes/types of screens (24-inch screen, laptop, tablet, smartphone) and on paper. Saliva will be collected after answering questionnaires. Heart rate variability and skin conductance will be measured with the use of a wrist watch during 15 minutes, from the entrance in the room to the completion of questionnaires.

The participant will undergo the same examination within a week (15 minutes).

Study Design

Study Type:
Observational
Anticipated Enrollment :
200 participants
Observational Model:
Cohort
Time Perspective:
Cross-Sectional
Official Title:
Influence of Screen Sizes on Responses to Visual Analog Scales of Stress
Actual Study Start Date :
Mar 2, 2021
Anticipated Primary Completion Date :
Mar 1, 2024
Anticipated Study Completion Date :
Mar 1, 2024

Arms and Interventions

Arm Intervention/Treatment
experimental group

differences in responses to visual analog scales depending on screen sizes

Other: Influence of screen sizes on responses to visual analog scales of stress
An open questionnaire will be created by the Clinical Research Direction. The questionnaire will be opened by the examinator who will fulfill the anonymized identification of participants and the type of screens. In a dedicated room at the LaPSCo, the participants will answer the same VAS on four different sizes/types of screens (24-inch screen, laptop, tablet, smartphone) and on paper. Saliva will be collected after answering questionnaires. Heart rate variability and skin conductance will be measured with the use of a wrist watch during 15 minutes, from the entrance in the room to the completion of questionnaires. The participant will undergo the same examination within a week (15 minutes).

Outcome Measures

Primary Outcome Measures

  1. Visual analog scale to assess the perceived stress [day 0]

    Visual analog scale to assess the perceived stress on a horizontal, non-calibrated line of 100 mm, ranging from very low (0) to very high (100)

  2. Visual analog scale to assess the perceived stress [day 7]

    Visual analog scale to assess the perceived stress on a horizontal, non-calibrated line of 100 mm, ranging from very low (0) to very high (100)

Secondary Outcome Measures

  1. Visual analog scale to assess anxiety [day 0, day 7]

    Visual analog scale to assess anxiety on a horizontal, non-calibrated line of 100 mm, ranging from very low (0) to very high (100)

  2. Visual analog scale to assess sleep quality [day 0, day 7]

    Visual analog scale to assess sleep quality on a horizontal, non-calibrated line of 100 mm, ranging from very low (0) to very high (100)

  3. Visual analog scale to assess fatigue [day 0, day 7]

    Visual analog scale to assess fatigue on a horizontal, non-calibrated line of 100 mm, ranging from very low (0) to very high (100)

  4. Job Demand-Control-Support (JDSC) questionnaire of Karasek [day 0, day 7]

    The Job Demand-Control-Support (JDSC) questionnaire of Karasek assessed job demands, job control and social support through 26 items.

  5. The Effort-Reward Imbalance Questionnaire (ERI) [day 0, day 7]

    The Effort-Reward Imbalance Questionnaire (ERI) is a self-administrated test assessing psychological distress and health problems that may occur when there is an imbalance between the efforts required by the work and the rewards received.

  6. The Work Addiction Risk Test (WART) [day 0, day 7]

    The Work Addiction Risk Test (WART) was developed by Robinson et al. from symptoms reported by clinicians caring for patients with work addiction

  7. Hospital Anxiety and Depression (HAD) Scale [day 0, day 7]

    Hospital Anxiety and Depression (HAD) Scale is a self-reported questionnaire composed of 14 items with a 4-point Likert scale assessing anxiety (7 items) and/or depressive (7 items) symptoms

  8. The Maslach Burn-out Inventory (MBI) [day 0, day 7]

    The Maslach Burn-out Inventory (MBI) is composed of 22 items designed to assess the three components of the burn-out syndrome: emotional exhaustion (9 items), depersonalization (5 items) and reduced personal accomplishment (8 items)

  9. Heart rate variability [day 0, day 7]

    Heart rate variability and skin conductance will be measured with the use of the wristband Empatica E4, Italy

  10. : skin conductance [day 0, day 7]

    Heart rate variability and skin conductance will be measured with the use of the wristband Empatica E4, Italy

  11. Salivary DHEAS [day 0, day 7]

    Salivary DHEAS is a biomarker of chronic stress, with a long half-life of 16 hours

Eligibility Criteria

Criteria

Ages Eligible for Study:
18 Years and Older
Sexes Eligible for Study:
All
Accepts Healthy Volunteers:
Yes
Inclusion Criteria:
  • Adult persons
Exclusion Criteria:
  • Refusal to participate in the study

  • Unable to answer basic questions (difficulties understanding, cognitive disorders…)

Contacts and Locations

Locations

Site City State Country Postal Code
1 Chu Clermont Ferrand Clermont-Ferrand France 63003

Sponsors and Collaborators

  • University Hospital, Clermont-Ferrand
  • Institut de Médecine du Travail
  • UMR CNRS 6024, LaPSCo

Investigators

  • Principal Investigator: frédéric Dutheil, University Hospital, Clermont-Ferrand

Study Documents (Full-Text)

None provided.

More Information

Publications

None provided.
Responsible Party:
University Hospital, Clermont-Ferrand
ClinicalTrials.gov Identifier:
NCT04040608
Other Study ID Numbers:
  • RNI 2018 DUTHEIL 3
  • 2018-A03280-55
First Posted:
Jul 31, 2019
Last Update Posted:
Apr 8, 2022
Last Verified:
Jul 1, 2021
Studies a U.S. FDA-regulated Drug Product:
No
Studies a U.S. FDA-regulated Device Product:
No
Keywords provided by University Hospital, Clermont-Ferrand

Study Results

No Results Posted as of Apr 8, 2022